Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4391)
All Articles published online
|
Dec 21, 2006 (publication date) through Mar 31, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Göbel T, Vorderwülbecke S, Hauck K, Fey H, Häussinger D, Erhardt A. New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples. World J Gastroenterol 2006; 12(47): 7604-7612 [PMID: 17171788 DOI: 10.3748/wjg.v12.i47.7604] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i47/7604.htm |
| Number | Citing Articles |
| 1 |
Andrea Hodgetts, Michael Levin, J Simon Kroll, Paul R Langford. Biomarker Discovery in Infectious Diseases Using SELDI. Future Microbiology 2007; 2(1): 35 doi: 10.2217/17460913.2.1.35
|
| 2 |
Dan Theodorescu, Harald Mischak. Mass spectrometry based proteomics in urine biomarker discovery. World Journal of Urology 2007; 25(5): 435 doi: 10.1007/s00345-007-0206-3
|
| 3 |
Valeria R. Mas, Daniel G. Maluf, Kellie J. Archer, Kenneth Yanek, Karen Bornstein, Robert A. Fisher. Proteomic Analysis of HCV Cirrhosis and HCV-Induced HCC: Identifying Biomarkers for Monitoring HCV-Cirrhotic Patients Awaiting Liver Transplantation. Transplantation 2009; 87(1): 143 doi: 10.1097/TP.0b013e318191c68d
|
| 4 |
L. Zhong, D. Taylor, D.J. Begg, R.J. Whittington. Biomarker discovery for ovine paratuberculosis (Johne's disease) by proteomic serum profiling. Comparative Immunology, Microbiology and Infectious Diseases 2011; 34(4): 315 doi: 10.1016/j.cimid.2011.03.001
|
| 5 |
Matthew L. Cowan, Tony M. Rahman, Sanjeev Krishna. Proteomic approaches in the search for biomarkers of liver fibrosis. Trends in Molecular Medicine 2010; 16(4): 171 doi: 10.1016/j.molmed.2010.01.006
|
| 6 |
Maria Paola Simula, Valli De Re. Hepatitis C virus‐induced oxidative stress and mitochondrial dysfunction: A focus on recent advances in proteomics. PROTEOMICS – Clinical Applications 2010; 4(10-11): 782 doi: 10.1002/prca.201000049
|
| 7 |
Corinna Henkel, Kristina Schwamborn, Henning W. Zimmermann, Frank Tacke, Elisabeth Kühnen, Margarete Odenthal, M. Reid Groseclose, Richard M. Caprioli, Ralf Weiskirchen. From proteomic multimarker profiling to interesting proteins: thymosin‐β4 and kininogen‐1 as new potential biomarkers for inflammatory hepatic lesions. Journal of Cellular and Molecular Medicine 2011; 15(10): 2176 doi: 10.1111/j.1582-4934.2010.01204.x
|
| 8 |
Sofiya Kolusheva, Rami Yossef, Aleksandra Kugel, Nirit Hanin-Avraham, Meital Cohen, Eitan Rubin, Angel Porgador. A Novel “Reactomics” Approach for Cancer Diagnostics. Sensors 2012; 12(5): 5572 doi: 10.3390/s120505572
|
| 9 |
Daniela Spano, Flora Cimmino, Mario Capasso, Fulvio D’Angelo, Nicola Zambrano, Luigi Terracciano, Achille Iolascon. Changes of the Hepatic Proteome in Hepatitis B-Infected Mouse Model at Early Stages of Fibrosis. Journal of Proteome Research 2008; 7(7): 2642 doi: 10.1021/pr7006522
|
| 10 |
Harald Tammen, Andrew Peck, Petra Budde, Hans-Dieter Zucht. Peptidomics analysis of human blood specimens for biomarker discovery. Expert Review of Molecular Diagnostics 2007; 7(5): 605 doi: 10.1586/14737159.7.5.605
|
| 11 |
Proteomic-genomic adjustments and their confluence for elucidation of pathways and networks during liver fibrosis. International Journal of Biological Macromolecules 2018; 111: 379 doi: 10.1016/j.ijbiomac.2017.12.168
|
| 12 |
Ying Lin, William S. Dynan, Jeffrey R. Lee, Zhao-Hua Zhu, Robert R. Schade. The Current State of Proteomics in GI Oncology. Digestive Diseases and Sciences 2009; 54(3): 431 doi: 10.1007/s10620-008-0656-5
|
| 13 |
Hind I. Fallatah. Noninvasive Biomarkers of Liver Fibrosis: An Overview. Advances in Hepatology 2014; 2014: 1 doi: 10.1155/2014/357287
|
| 14 |
Yoshiyuki Takahara, Mitsuo Takahashi, Qing-Wei Zhang, Hirotaka Wagatsuma, Maiko Mori, Akihiro Tamori, Susumu Shiomi, Shuhei Nishiguchi. Serial changes in expression of functionally clustered genes in progression of liver fibrosis in hepatitis C patients. World Journal of Gastroenterology 2008; 14(13): 2010-2022 doi: 10.3748/wjg.14.2010
|
| 15 |
Alessandra Tessitore, Agata Gaggiano, Germana Cicciarelli, Daniela Verzella, Daria Capece, Mariafausta Fischietti, Francesca Zazzeroni, Edoardo Alesse. Serum Biomarkers Identification by Mass Spectrometry in High-Mortality Tumors. International Journal of Proteomics 2013; 2013: 1 doi: 10.1155/2013/125858
|
| 16 |
M.A. Karpova, S.A. Moshkovskii, I.Y. Toropygin, A.I. Archakov. Cancer-specific MALDI-TOF profiles of blood serum and plasma: Biological meaning and perspectives. Journal of Proteomics 2010; 73(3): 537 doi: 10.1016/j.jprot.2009.09.011
|
| 17 |
Maria Ercibengoa, Marta Alonso. The Use of Mass Spectrometry Technology (MALDI-TOF) in Clinical Microbiology. 2018; : 255 doi: 10.1016/B978-0-12-814451-0.00017-4
|
| 18 |
Kara Rye, Robert Scott, Gerri Mortimore, Adam Lawson, Andrew Austin, Jan Freeman. Towards Noninvasive Detection of Oesophageal Varices. International Journal of Hepatology 2012; 2012: 1 doi: 10.1155/2012/343591
|
| 19 |
Abdel Aziz M. Shaheen, Robert P. Myers. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C–related fibrosis: A systematic review. Hepatology 2007; 46(3): 912 doi: 10.1002/hep.21835
|
| 20 |
Meital Cohen, Rami Yossef, Tamir Erez, Aleksandra Kugel, Michael Welt, Mark M. Karpasas, Jonathan Bones, Pauline M. Rudd, Julien Taieb, Herve Boissin, Dror Harats, Karin Noy, Yoram Tekoah, Rachel G. Lichtenstein, Eitan Rubin, Angel Porgador, Hana Algül. Serum Apolipoproteins C-I and C-III Are Reduced in Stomach Cancer Patients: Results from MALDI-Based Peptidome and Immuno-Based Clinical Assays. PLoS ONE 2011; 6(1): e14540 doi: 10.1371/journal.pone.0014540
|
| 21 |
Shi-Qiang Shen, Kun Li, Neng Zhu, Akimasa Nakao. Expression and clinical significance of NET-1 and PCNA in hepatocellular carcinoma. Medical Oncology 2008; 25(3): 341 doi: 10.1007/s12032-008-9042-6
|
| 22 |
Junjie Zhang, Fei Guo, Lei Wang, Wei Zhao, Da Zhang, Heying Yang, Jiekai Yu, Lili Niu, Fuquan Yang, Shu Zheng, Jiaxiang Wang. Identification of Apolipoprotein C-I as a Potential Wilms’ Tumor Marker after Excluding Inflammatory Factors. International Journal of Molecular Sciences 2014; 15(9): 16186 doi: 10.3390/ijms150916186
|
| 23 |
Fernando Bril, Ryan W Pearce, Timothy S Collier, Michael J McPhaul. Differences in HDL-Bound Apolipoproteins in Patients With Advanced Liver Fibrosis Due to Nonalcoholic Fatty Liver Disease. The Journal of Clinical Endocrinology & Metabolism 2022; 108(1): 42 doi: 10.1210/clinem/dgac565
|
| 24 |
Rebekka A Hannivoort, Virginia Hernandez-Gea, Scott L Friedman. Genomics and proteomics in liver fibrosis and cirrhosis. Fibrogenesis & Tissue Repair 2012; 5(1) doi: 10.1186/1755-1536-5-1
|
| 25 |
Marwa K. Ibrahim, Hosny Salama, Mohamad Abd El Rahman, Reham M. Dawood, Noha G. Bader El Din, Heba F. Salem, Mohamed E.A. Abdelrahim, Dalia Omran, Moataza H. Omran, Khaled Helmi El-Wakeel, Tawfeek H. Abdelhafez, Ahmed Khedr, Mostafa K. El Awady. Three Gene Signature for Predicting the Development of Hepatocellular Carcinoma in Chronically Infected Hepatitis C Virus Patients. Journal of Interferon & Cytokine Research 2016; 36(12): 698 doi: 10.1089/jir.2016.0042
|
| 26 |
Lauren N. Bell, Janice L. Theodorakis, Raj Vuppalanchi, Romil Saxena, Kerry G. Bemis, Mu Wang, Naga Chalasani. Serum Proteomics and Biomarker Discovery Across the Spectrum of Nonalcoholic Fatty Liver Disease. Hepatology 2010; 51(1): 111 doi: 10.1002/hep.23271
|
| 27 |
Momar Ndao. SELDI-TOF Mass Spectrometry. Methods in Molecular Biology 2012; 818: 67 doi: 10.1007/978-1-61779-418-6_5
|
| 28 |
Eleonora Forte, Jes M. Sanders, Indira Pla, Vijaya Lakshmi Kanchustambham, Michael A.R. Hollas, Che-Fan Huang, Aniel Sanchez, Katrina N. Peterson, Rafael D. Melani, Alexander Huang, Praneet Polineni, Julianna M. Doll, Zachary Dietch, Neil L. Kelleher, Daniela P. Ladner. Top-Down Proteomics Identifies Plasma Proteoform Signatures of Liver Cirrhosis Progression. Molecular & Cellular Proteomics 2024; 23(12): 100876 doi: 10.1016/j.mcpro.2024.100876
|
| 29 |
Anuradha Budhu, Junfang Ji, Xin Wei Wang. Hepatocellular Carcinoma. 2009; : 131 doi: 10.1007/978-1-60327-376-3_5
|
| 30 |
Stephanie Roessler, Anuradha Budhu, Xin Wei Wang. Future of Molecular Profiling of Human Hepatocellular Carcinoma. Future Oncology 2007; 3(4): 429 doi: 10.2217/14796694.3.4.429
|
| 31 |
Kin Jip Cheung, Kelly Tilleman, Dieter Deforce, Isabelle Colle, Hans Van Vlierberghe. Proteomics in liver fibrosis is more than meets the eye. European Journal of Gastroenterology & Hepatology 2008; 20(5): 450 doi: 10.1097/MEG.0b013e3282f4de92
|
| 32 |
Kamlesh K. Bhopale, Samir M. Amer, Lata Kaphalia, Kizhake V. Soman, John E. Wiktorowicz, Ghulam A. Shakeel Ansari, Bhupendra S. Kaphalia. Proteomic Profiling of Liver and Plasma in Chronic Ethanol Feeding Model of Hepatic Alcohol Dehydrogenase-Deficient Deer Mice. Alcoholism: Clinical and Experimental Research 2017; 41(10): 1675 doi: 10.1111/acer.13470
|
| 33 |
|
| 34 |
Momar Ndao, Adam Rainczuk, Marie-Claire Rioux, Terry W. Spithill, Brian J. Ward. Is SELDI-TOF a valid tool for diagnostic biomarkers?. Trends in Parasitology 2010; 26(12): 561 doi: 10.1016/j.pt.2010.07.004
|
| 35 |
Judith Y.M.N. Engwegen, Annekatrien C.T.M. Depla, Marianne E. Smits, Annemieke Cats, Henriëtte Tuynman, Henk A. Van Heukelem, Pleun Snel, Wouter Meuleman, Lodewyk F. Wessels, Jan H.M. Schellens, Jos H. Beijnen. Detection of Colorectal Cancer by Serum and Tissue Protein Profiling: A Prospective Study in a Population at Risk. Biomarker Insights 2008; 3: BMI.S790 doi: 10.4137/BMI.S790
|
| 36 |
Perumal Vivekanandan, Om V Singh. High-dimensional biology to comprehend hepatocellular carcinoma. Expert Review of Proteomics 2008; 5(1): 45 doi: 10.1586/14789450.5.1.45
|
| 37 |
ShuLong Li, Xin Liu, Lai Wei, HuiFen Wang, JiYang Zhang, HanDong Wei, XiaoHong Qian, Ying Jiang, FuChu He. Plasma biomarker screening for liver fibrosis with the N-terminal isotope tagging strategy. Science China Life Sciences 2011; 54(5): 393 doi: 10.1007/s11427-011-4165-y
|
| 38 |
J. O. SMITH, R. K. STERLING. Systematic review: non‐invasive methods of fibrosis analysis in chronic hepatitis C. Alimentary Pharmacology & Therapeutics 2009; 30(6): 557 doi: 10.1111/j.1365-2036.2009.04062.x
|
| 39 |
Catriona Crossan, Emmanuel A Tsochatzis, Louise Longworth, Kurinchi Gurusamy, Brian Davidson, Manuel Rodríguez-Perálvarez, Konstantinos Mantzoukis, Julia O’Brien, Evangelos Thalassinos, Vassilios Papastergiou, Andrew Burroughs. Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation. Health Technology Assessment 2015; 19(9): 1 doi: 10.3310/hta19090
|
| 40 |
Farid E. Ahmed. The role of capillary electrophoresis–mass spectrometry to proteome analysis and biomarker discovery. Journal of Chromatography B 2009; 877(22): 1963 doi: 10.1016/j.jchromb.2009.05.023
|